Earnings Call · Q4 FY2025·2026-03-31

Q4 25EPS +28.57%·Rev n/aQ3 25EPS +36.26%·Rev n/aQ2 25EPS +56.91%·Rev n/aQ1 25EPS +21.67%·Rev n/a⚠ consensus missing

Imunon, Inc. IMNN

Peter Vozzo — Investor Relations

Stacy Lindborg — Chief Executive Officer

Douglas V. Faller — Chief Medical Officer

Jeffrey W. Church — Interim Chief Financial Officer

+2.1%1d on move date−0.8% vs SPY3d+11.8%5d+8.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMNN calls or request research access.

More IMNN calls Browse calls Request research access